FDA Drug recall D-1130-2019
Bismuth Subsalicylate Oral Suspension 262mg/15mL, unit dose cups, OTC, Rpkg
- FDA Drug
- Class II
- terminated
- Published 2019-04-17
On 2019-04-17 the FDA classified a Class II recall of Bismuth Subsalicylate Oral Suspension 262mg/15mL, unit dose cups, OTC, Rpkg by Lohxa, citing labeling: Incorrect or Missing Lot and/or Exp Date - the label contains an incorrect Exp Date.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1130-2019 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2019-03-25 |
| Published | 2019-04-17 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Lohxa |
| Distribution | MA, NY, WY |
Product
Bismuth Subsalicylate Oral Suspension 262mg/15mL, unit dose cups, OTC, Rpkg. By.: Lohxa Worcester, MA, NDC 70166-059-01
Reason
Labeling: Incorrect or Missing Lot and/or Exp Date - the label contains an incorrect Exp Date.
Identifiers
| code_info | Lot#: M030042P, Exp. 01/2020 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1130-2019%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.